Daiichi Sankyo Healthcare To Launch H2 Blocker Liquid Digestive Drug
This article was originally published in PharmAsia News
Executive Summary
Daiichi Sankyo Healthcare will launch Gaster 10 liquid digestive drug Oct. 16, the first H2-receptor antagonist liquid digestive drug in Japan, the company announced Oct. 9. The product is also combined with famotidine, an ingredient to constrain stomach acid. (Click here for more - Japanese language